Clinical laboratories, the bedrock of modern healthcare, face an escalating array of potential disruptions that threaten their capacity to deliver…
Read More
Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid Biopsy
A pioneering development from researchers at the Johns Hopkins Kimmel Cancer Center is set to significantly enhance the accuracy and…
Read More
New Orleans Gears Up for 31st Annual Executive War College, Focusing on Digital Pathology, AI, and Critical Lab Leadership Strategies
The 31st Annual Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, slated for April 28–29 in the vibrant…
Read More
Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Lab Models
The landscape of healthcare diagnostics is undergoing a profound transformation, with walk-in lab testing emerging as a pivotal force in…
Read More
Industry Innovators to Reveal High-Performance Strategies at 31st Annual Executive War College
The clinical laboratory sector stands at a critical juncture, navigating what industry analysts describe as a "perfect storm" of converging…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
Doherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.
Researchers at the prestigious Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, have announced a groundbreaking advancement in…
Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…
Read More
Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…
Read More
Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.
The landscape of clinical diagnostics is on the cusp of a significant transformation, with new research pointing towards a rapid,…
Read More
